Kolinsky Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$339K Buy
439
+14
+3% +$11.6K 0.21% 106
2024
Q3
$377K Buy
425
+72
+20% +$64.7K 0.24% 94
2024
Q2
$320K Buy
353
+95
+37% +$76K 0.23% 103
2024
Q1
$201K Buy
+258
New +$184K 0.15% 141
2022
Q2
Sell
-784
Closed -$225K 137
2022
Q1
$225K Sell
784
-17
-2% -$4.38K 0.22% 121
2021
Q4
$221K Buy
+801
New +$203K 0.2% 127

Other funds holding LLY

Kolinsky Wealth Management's LLY Position: Q4 2024 in Review

Kolinsky Wealth Management increased its Eli Lilly (LLY) stake by 3.3% in Q4 2024, buying an estimated $11.6K and bringing the position to 439 shares worth $339K. The position accounts for 0.21% of the portfolio, ranked #106.

Kolinsky Wealth Management first reported a position in LLY in Q4 2021 and has held it in 6 quarters since. The position peaked at $377K in Q3 2024. 3,913 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Kolinsky Wealth Management held 439 shares of Eli Lilly worth $339K as of Q4 2024.
  • Kolinsky Wealth Management bought 14 Eli Lilly shares in Q4 2024, an estimated $11.6K.
  • Eli Lilly made up 0.21% of Kolinsky Wealth Management's portfolio in Q4 2024, its #106 holding.
  • Kolinsky Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 6 quarters since.
  • Kolinsky Wealth Management's Eli Lilly position peaked at $377K in Q3 2024.
  • 3,913 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Kolinsky Wealth Management's 13F filing for Q4 2024, filed 18 Feb 2025.